πŸ‡ΊπŸ‡Έ FDA
Patent

US 11952352

Ras inhibitors

granted A61PA61P35/00

Quick answer

US patent 11952352 (Ras inhibitors) held by Revolution Medicines, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00